World's Best Scientists 2026 revealed!
Carcinogenesis
H-index 29

Carcinogenesis

0143-3334

Published by: Oxford University Press

https://academic.oup.com/carcin

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 863 240 166 25

Additional Metrics

Number of Best Scientists*: 453
Documents by Best Scientists*: 278
Top 100 Ranked Scientists*: 17
SCIMAGO H-index: 227
SCIMAGO SJR: 0.978
Impact Factor: 2.9

Overview

Top Research Topics at Carcinogenesis?

The journal was organized to reinforce research efforts on Biochemistry, Internal medicine, Molecular biology, Carcinogen and Cancer research. The in-depth study on Biochemistry also explores topics in the intersecting field of Adduct. The concepts on Internal medicine presented in Carcinogenesis can also apply to other research fields, including Gastroenterology, Endocrinology, Oncology and Genotype.

The research on Endocrinology featured in the journal combines topics in other fields like Anticarcinogen, Tumor promotion and Hepatocyte. The research on Molecular biology tackled can also make contributions to studies in the areas of Cell culture, DNA damage and Mutation, Gene, DNA repair. The journal holds forums on Cell culture that merges themes from other disciplines such as Cell and In vitro.

In addition to Carcinogen research, the journal aims to explore topics under Metabolite, Toxicity and In vivo. In the journal, Carcinogenesis, Cancer, Cell growth, Apoptosis and Signal transduction are investigated in conjunction with one another to address concerns in Cancer research research. Carcinogenesis study tackled is connected to the field of Pathology.

  • Biochemistry (29.83%)
  • Internal medicine (27.42%)
  • Molecular biology (23.73%)

What are the most cited papers published in the journal?

  • Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. (1907 citations)
  • Epigenetics in Cancer (1698 citations)
  • Oxyradicals and DNA damage (1598 citations)

Research areas of the most cited articles at Carcinogenesis:

The published articles generally zeroe in on subjects such as Biochemistry, Internal medicine, Cancer research, Endocrinology and Carcinogen. In addition to Biochemistry research, the published papers aim to explore topics under Molecular biology and Pharmacology. While Cancer research is the focus of the most cited papers, it also provides insights into the studies of Cancer cell, Cancer, Carcinogenesis, Cell growth and Apoptosis.

What topics the last edition of the journal is best known for?

  • Gene
  • Enzyme
  • Internal medicine

The previous edition focused in particular on these issues:

The journal tackles a plethora of topics, such as Cancer research, Carcinogenesis, Cancer, Internal medicine and Gene knockdown. The studies in Cancer research featured incorporate elements of Cell growth, Cancer cell, Apoptosis, Downregulation and upregulation and Signal transduction. Cell growth research presented in the journal encompasses a variety of subjects, including Cell cycle, Gene silencing and Gene.

While it focused on Carcinogenesis, it was also able to explore topics like Prostate, Inflammation, Immune system, YAP1 and Stem cell. Specifically, studies on Tumor progression are prevalent in the Cancer works discussed. It focuses on Internal medicine but the discussions also offer insight into other areas such as Gastroenterology and Oncology.

The most cited articles from the last journal are:

  • Transforming growth factor beta orchestrates PD-L1 enrichment in tumor-derived exosomes and mediates CD8 T-cell dysfunction regulating early phosphorylation of TCR signalome in breast cancer (8 citations)
  • Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR1–3 signaling, but not FGFR4 signaling (8 citations)
  • Alteration of fecal microbiota by fucoxanthin results in prevention of colorectal cancer in AOM/DSS mice. (7 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Carcinogenesis (based on the number of publications) are:

  • Stephen S. Hecht (108 papers) absent at the last edition,
  • Kari Hemminki (88 papers) absent at the last edition,
  • Helmut Bartsch (80 papers) absent at the last edition,
  • Takashi Sugimura (72 papers) absent at the last edition,
  • Qingyi Wei (67 papers) published 1 paper at the last edition, 1 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Carcinogenesis (based on the number of publications) are:

  • National Institutes of Health (656 papers) published 6 papers at the last edition the same number as at the previous edition,
  • University of Texas MD Anderson Cancer Center (280 papers) published 5 papers at the last edition, 3 less than at the previous edition,
  • Karolinska Institutet (242 papers) published 1 paper at the last edition the same number as at the previous edition,
  • German Cancer Research Center (237 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • International Agency for Research on Cancer (220 papers) published 2 papers at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 2.80% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 12.95% were posted by at least one author from the top 10 institutions publishing in the journal. Another 5.04% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 11.51% of all publications and 70.50% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Carcinogenesis Research

Understanding the vast landscape of Carcinogenesis can pave the way to various career paths in the field. One of the potential roles that researchers can venture into is becoming a Nurse Practitioner specialized in Oncology. Nurse Practitioners play a crucial role in patient care. To begin this journey, an aspiring Nurse Practitioner needs to complete a specific set of requirements, which involves obtaining a bachelor's degree, gaining experience as a registered nurse, and acquiring a master's degree in nursing. Specialty certification in Oncology may not be required but is highly beneficial. Cost, location, practicum experience, and curriculum are among the factors to consider when choosing a school to pursue a Nurse Practitioner degree. In-depth research, comprehensive education, and essential work experience fuse together to build the required competencies of a Nurse Practitioner focused on Oncology. To learn more about this path, you can read our guide on how to be a nurse practitioner in Utah. Understanding the dynamics of Carcinogenesis research entails not only a grasp of the complex scientific concepts but also an insight into the potential opportunities that can be explored within this field. After all, the purpose of research is to widen our knowledge and pave ways to utilize this knowledge in practical and meaningful ways.

Top Publications

  • Osteosarcoma cell-derived exosomes affect tumor microenvironment by specific packaging of microRNAs

    Lavinia Raimondi;Angela De Luca;Alessia Gallo;Viviana Costa

    (2020)
    97 Citations
  • miR-155 as a novel clinical target for hematological malignancies.

    Lisa Witten;Frank J Slack

    (2020)
    81 Citations
  • Tumor-derived exosomes promote carcinogenesis of murine oral squamous cell carcinoma.

    Beatrice M Razzo;Beatrice M Razzo;Nils Ludwig;Chang-Sook Hong;Priyanka Sharma

    (2020)
    73 Citations
  • Plasma hsa_circ_0027089 is a diagnostic biomarker for hepatitis B virus-related hepatocellular carcinoma.

    Kai Zhu;Hao Zhan;Yuanfei Peng;Liuxiao Yang

    (2020)
    62 Citations
  • MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment.

    Donald W Kufe

    (2020)
    61 Citations
  • Andrographis-mediated chemosensitization through activation of ferroptosis and suppression of β-catenin/Wnt-signaling pathways in colorectal cancer.

    Priyanka Sharma;Priyanka Sharma;Tadanobu Shimura;Jasjit K Banwait;Ajay Goel;Ajay Goel

    (2020)
    60 Citations
  • LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinoma.

    Yasuyuki Okada;Yasuyuki Okada;Naoki Takahashi;Tetsuji Takayama;Ajay Goel

    (2021)
    53 Citations
  • Targeting cellular senescence in cancer and aging: roles of p53 and its isoforms

    Jessica Beck;Jessica Beck;Casmir Turnquist;Casmir Turnquist;Izumi Horikawa;Curtis Harris

    (2020)
    49 Citations
  • EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2

    Shengnan Chen;Shengnan Chen;Tang Youhong;Yixin Tan;Yuxiang He

    (2020)
    48 Citations
  • TIMP-2 suppresses tumor growth and metastasis in murine model of triple-negative breast cancer.

    David Peeney;Sandra M Jensen;Nadia P Castro;Sarvesh Kumar

    (2020)
    47 Citations

Related Online Degrees & Career Pathways

For those interested in healthcare but not pursuing a traditional medical degree, there are several alternative career pathways to consider. Medical coding, for example, is a growing field with competitive medical coding jobs salary that reflects the specialized skills required to accurately translate medical records into standardized codes.

Understanding the medical coding job outlook is crucial before entering the field. It offers stability and remote work options, though it demands precision and ongoing education to keep pace with industry changes.

For students aiming to broaden their qualifications, earning a HIM degree online can open doors to roles in health information management and data analytics—key areas that support clinical operations and healthcare policy.

Alternatively, pursuing an online master's degree in nutrition enables individuals to specialize in dietetics, wellness coaching, or clinical nutrition, aligning with the growing focus on preventive medicine and holistic health.

Best Scientists Contributing to This Journal